Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/harmony-biosciences-announces-exclusive-agreement-to-develop-and-commercialize-tpm-1116-a-highly-potent-and-selective-oral-orexin-2-receptor-agonist-302113794.html
https://www.prnewswire.com/news-releases/harmony-biosciences-initiates-global-phase-3-registrational-trial-tempo-study-of-pitolisant-in-patients-with-prader-willi-syndrome-302106423.html
https://ir.harmonybiosciences.com/news-releases/news-release-details/harmony-biosciences-participate-23rd-annual-needham-virtual
https://ir.harmonybiosciences.com/news-releases/news-release-details/harmony-biosciences-certified-great-place-workr-sixth
https://www.globenewswire.com//news-release/2024/02/22/2833569/0/en/Harmony-Biosciences-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Business-Updates.html
https://www.prnewswire.com/news-releases/harmony-biosciences-receives-us-food-and-drug-administration-orphan-drug-designation-for-pitolisant-in-prader-willi-syndrome-302065480.html
https://www.prnewswire.com/news-releases/harmony-biosciences-announces-positive-topline-data-from-phase-2-signal-detection-study-evaluating-pitolisant-in-adult-patients-with-myotonic-dystrophy-type-1-302008352.html
https://www.prnewswire.com/news-releases/harmony-biosciences-ranked-among-top-25-fastest-growing-companies-in-north-america-on-the-2023-deloitte-technology-fast-500-301988289.html
https://www.globenewswire.com//news-release/2023/10/31/2770056/0/en/Harmony-Biosciences-Reports-Strong-Third-Quarter-2023-Financial-Results.html
https://www.prnewswire.com/news-releases/harmony-biosciences-announces-topline-data-from-phase-3-intune-study-evaluating-pitolisant-in-patients-with-idiopathic-hypersomnia-301955736.html